Skip to content

Author

Dong-Yun Zhan

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Omentin-1 and cardiovascular disease: a comprehensive review from molecular mechanisms to clinical translation

Emerging evidence that commonly used cardiometabolic drugs can modulate omentin-1 levels is highlighted, supporting its potential as both a biomarker and a therapeutic target and highlighting recent advances in clinical research.

Ying-Cang Zhang, Wei Hao, Mei-Qi Luan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.